S&P 500   3,327.97 (-0.05%)
DOW   29,331.30 (-0.06%)
QQQ   223.62 (+0.11%)
AAPL   318.67 (-0.02%)
FB   221.13 (-0.45%)
MSFT   167.58 (+0.29%)
AMZN   1,873.46 (+0.47%)
CGC   24.69 (-0.80%)
BABA   221.89 (-2.44%)
GE   11.67 (-1.27%)
AMD   51.28 (+0.69%)
T   38.45 (+0.18%)
ACB   2.06 (-3.29%)
NFLX   337.14 (-0.74%)
BAC   34.48 (-0.66%)
GILD   62.74 (-0.38%)
DIS   143.80 (-0.37%)
S&P 500   3,327.97 (-0.05%)
DOW   29,331.30 (-0.06%)
QQQ   223.62 (+0.11%)
AAPL   318.67 (-0.02%)
FB   221.13 (-0.45%)
MSFT   167.58 (+0.29%)
AMZN   1,873.46 (+0.47%)
CGC   24.69 (-0.80%)
BABA   221.89 (-2.44%)
GE   11.67 (-1.27%)
AMD   51.28 (+0.69%)
T   38.45 (+0.18%)
ACB   2.06 (-3.29%)
NFLX   337.14 (-0.74%)
BAC   34.48 (-0.66%)
GILD   62.74 (-0.38%)
DIS   143.80 (-0.37%)
S&P 500   3,327.97 (-0.05%)
DOW   29,331.30 (-0.06%)
QQQ   223.62 (+0.11%)
AAPL   318.67 (-0.02%)
FB   221.13 (-0.45%)
MSFT   167.58 (+0.29%)
AMZN   1,873.46 (+0.47%)
CGC   24.69 (-0.80%)
BABA   221.89 (-2.44%)
GE   11.67 (-1.27%)
AMD   51.28 (+0.69%)
T   38.45 (+0.18%)
ACB   2.06 (-3.29%)
NFLX   337.14 (-0.74%)
BAC   34.48 (-0.66%)
GILD   62.74 (-0.38%)
DIS   143.80 (-0.37%)
S&P 500   3,327.97 (-0.05%)
DOW   29,331.30 (-0.06%)
QQQ   223.62 (+0.11%)
AAPL   318.67 (-0.02%)
FB   221.13 (-0.45%)
MSFT   167.58 (+0.29%)
AMZN   1,873.46 (+0.47%)
CGC   24.69 (-0.80%)
BABA   221.89 (-2.44%)
GE   11.67 (-1.27%)
AMD   51.28 (+0.69%)
T   38.45 (+0.18%)
ACB   2.06 (-3.29%)
NFLX   337.14 (-0.74%)
BAC   34.48 (-0.66%)
GILD   62.74 (-0.38%)
DIS   143.80 (-0.37%)
Log in
(Ad)
I call it my "Dividend Map", and I'll show you exactly where to find the safest companies that pay the highest yields. (HINT: Texas has 6 of these companies sending huge payouts that average 77%!). I'm willing to send you my Map... but only if you

NASDAQ:NEOS - Neos Therapeutics Stock Price, Forecast & News

$1.60
0.00 (0.00 %)
(As of 01/21/2020 12:01 PM ET)
Today's Range
$1.57
Now: $1.60
$1.61
50-Day Range
$1.37
MA: $1.49
$1.60
52-Week Range
$1.13
Now: $1.60
$3.62
Volume51,268 shs
Average Volume181,149 shs
Market Capitalization$79.57 million
P/E RatioN/A
Dividend YieldN/A
Beta0.96
Neos Therapeutics, Inc, a pharmaceutical company, develops, manufactures, and commercializes products for the treatment of attention deficit hyperactivity disorder (ADHD) using its drug delivery technology platform. Its products are extended-release (XR) medications in orally disintegrating tablets or liquid suspension dosage forms. The company manufactures and markets Adzenys XR-ODT amphetamine for the treatment of ADHD; Cotempla XR-ODT methylphenidate for treating of ADHD; Adzenys ER amphetamine to treat ADHD; and generic Tussionex hydrocodone and chlorpheniramine for cough and upper respiratory symptoms of a cold. Read More…

Industry, Sector and Symbol

Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:NEOS
CUSIPN/A
Phone972-408-1300

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$49.99 million
Book Value$0.16 per share

Profitability

Net Income$-51,670,000.00

Miscellaneous

Employees215
Market Cap$79.57 million
Next Earnings Date3/12/2020 (Estimated)
OptionableOptionable

Receive NEOS News and Ratings via Email

Sign-up to receive the latest news and ratings for NEOS and its competitors with MarketBeat's FREE daily newsletter.


(Ad)


Investors looking for the best way to potentially double their money in 2020 -- regardless of whether the overall markets are up or down -- should look no further than these 3 unique stocks.

This Special Report reveals the names of these stocks and provides everything you need to invest right away.

Neos Therapeutics (NASDAQ:NEOS) Frequently Asked Questions

What is Neos Therapeutics' stock symbol?

Neos Therapeutics trades on the NASDAQ under the ticker symbol "NEOS."

How were Neos Therapeutics' earnings last quarter?

Neos Therapeutics Inc (NASDAQ:NEOS) issued its earnings results on Friday, November, 8th. The company reported ($0.04) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.11) by $0.07. The company earned $17.54 million during the quarter. Neos Therapeutics had a negative net margin of 35.77% and a negative return on equity of 2,087.24%. View Neos Therapeutics' Earnings History.

When is Neos Therapeutics' next earnings date?

Neos Therapeutics is scheduled to release their next quarterly earnings announcement on Thursday, March 12th 2020. View Earnings Estimates for Neos Therapeutics.

What price target have analysts set for NEOS?

2 brokerages have issued 12-month target prices for Neos Therapeutics' shares. Their forecasts range from $3.00 to $10.00. On average, they expect Neos Therapeutics' stock price to reach $6.50 in the next year. This suggests a possible upside of 306.3% from the stock's current price. View Analyst Price Targets for Neos Therapeutics.

What is the consensus analysts' recommendation for Neos Therapeutics?

2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Neos Therapeutics in the last year. There are currently 1 hold rating and 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Neos Therapeutics.

Has Neos Therapeutics been receiving favorable news coverage?

News coverage about NEOS stock has been trending very positive this week, InfoTrie Sentiment Analysis reports. The research firm rates the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Neos Therapeutics earned a media sentiment score of 4.0 on InfoTrie's scale. They also assigned media stories about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the next few days. View News Stories for Neos Therapeutics.

Are investors shorting Neos Therapeutics?

Neos Therapeutics saw a increase in short interest in December. As of December 13th, there was short interest totalling 2,160,000 shares, an increase of 10.8% from the November 28th total of 1,950,000 shares. Based on an average daily volume of 173,400 shares, the short-interest ratio is currently 12.5 days. Currently, 4.4% of the shares of the stock are sold short. View Neos Therapeutics' Current Options Chain.

Who are some of Neos Therapeutics' key competitors?

What other stocks do shareholders of Neos Therapeutics own?

Who are Neos Therapeutics' key executives?

Neos Therapeutics' management team includes the folowing people:
  • Mr. Richard I. Eisenstadt, CFO, Treasurer & Corp. Sec. (Age 61)
  • Mr. Gerald W. McLaughlin, CEO, Pres & Director (Age 51)
  • Mr. John P. Limongelli, Sr. VP & Gen. Counsel (Age 49)
  • Mr. Darren Heath, VP of Sales
  • Mr. Russ McMahen, Sr. VP of R&D

When did Neos Therapeutics IPO?

(NEOS) raised $60 million in an IPO on Thursday, July 23rd 2015. The company issued 4,000,000 shares at $14.00-$16.00 per share. UBS Investment Bank, BMO Capital Markets and RBC Capital Markets acted as the underwriters for the IPO and JMP Securities was co-manager.

How do I buy shares of Neos Therapeutics?

Shares of NEOS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Neos Therapeutics' stock price today?

One share of NEOS stock can currently be purchased for approximately $1.60.

How big of a company is Neos Therapeutics?

Neos Therapeutics has a market capitalization of $79.57 million and generates $49.99 million in revenue each year. The company earns $-51,670,000.00 in net income (profit) each year or ($1.60) on an earnings per share basis. Neos Therapeutics employs 215 workers across the globe.View Additional Information About Neos Therapeutics.

What is Neos Therapeutics' official website?

The official website for Neos Therapeutics is http://www.neostx.com/.

How can I contact Neos Therapeutics?

Neos Therapeutics' mailing address is 2940 N. HIGHWAY 360, GRAND PRAIRIE TX, 75050. The company can be reached via phone at 972-408-1300 or via email at [email protected]


MarketBeat Community Rating for Neos Therapeutics (NASDAQ NEOS)

Community Ranking:  3.1 out of 5 (star star star)
Outperform Votes:  457 (Vote Outperform)
Underperform Votes:  283 (Vote Underperform)
Total Votes:  740
MarketBeat's community ratings are surveys of what our community members think about Neos Therapeutics and other stocks. Vote "Outperform" if you believe NEOS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe NEOS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel